Aflibercept versus ranibizumab for treating persistent diabetic macular oedema

The purpose of this study was to compare the efficacy of intravitreal aflibercept versus ranibizumab for treating therapy-resistant diabetic macular oedema (DME). A 69-year-old man presented with persistent bilateral DME despite previous ranibizumab treatment. Bilateral study treatment comprised one...

Descripción completa

Detalles Bibliográficos
Autor principal: ROA Vandekerckhove, Kristof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488481/
https://www.ncbi.nlm.nih.gov/pubmed/25989873
http://dx.doi.org/10.1007/s10792-015-0081-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488481/
https://www.ncbi.nlm.nih.gov/pubmed/25989873
http://dx.doi.org/10.1007/s10792-015-0081-7

Ejemplares similares